At Mercola.com, Dr. Joseph Mercola discusses the little-known cardiovascular-kidney-metabolic (CKM) syndrome. He writes:
Nearly 90% of U.S. adults have at least one risk factor for...
In a recent email, Harvard Medical School wrote:
A stroke can strike suddenly, robbing you of movement, speech, or even independence. But here's the good...
At Mercola.com, Dr. Joseph Mercola discusses beta blockers and research into their effectiveness. He writes:
A large trial tracked 8,438 heart attack patients, and the...
At Mercola.com, Dr. Joseph Mercola discusses the risk of nanoplastics associated with heart attacks and strokes. He writes:
Nanoplastics — particles less than 1 micrometer...
UPDATE 3.28.23: Beware the marketing of cholesterol-fighting drugs. A new cholesterol-fighting drug, bempedoic, branded Nexletol, is using a similar marketing strategy as statins. Here...